Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advil label changes

This article was originally published in The Tan Sheet

Executive Summary

Labeling for Advil Cold & Sinus tablets and liqui-gels will now carry the warning, "Ask a doctor or pharmacist before use if you are taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin," according to an updated version of FDA's MedWatch website. An ad campaign by aspirin manufacturer Bayer in 2003 pointed to studies showing that ibuprofen may interfere with the benefits of low-dose aspirin (1"The Tan Sheet" Nov. 17, 2003, p. 5). Modifications also are being made to several of Wyeth's children's products to include allergy warnings. The "Allergy Alert" portion of the Drug Facts Panel "has been revised to include a warning for aspirin sensitive individuals and a description of early symptoms associated with Stevens-Johnson Syndrome (SJS)" for Children's Advil Cold, Children's Advil Allergy Sinus, Children's Advil Chewables and Infant's Advil, the MedWatch website notes...

You may also be interested in...



Bayer Ad Cites NSAID Interference With Aspirin Heart Benefits

Bayer is cautioning consumers against the use of non-steroidal anti-inflammatory drugs in conjunction with aspirin use for heart health in a recently launched television ad campaign

European CHMP Opinions and MAA Updates

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.

UK’s NICE Backs Two Microsphere Products For Liver Cancer But Says No To Another

Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.

Topics

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel